00090 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
00100 - Statement - CONSOLIDATED BALANCE SHEETS
link:presentationLink
link:calculationLink
link:definitionLink
00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS
link:presentationLink
link:calculationLink
link:definitionLink
00300 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME (LOSS)
link:presentationLink
link:calculationLink
link:definitionLink
00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS
link:presentationLink
link:calculationLink
link:definitionLink
00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
10101 - Disclosure - NATURE OF OPERATIONS AND BUSINESS RISKS
link:presentationLink
link:calculationLink
link:definitionLink
10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
link:presentationLink
link:calculationLink
link:definitionLink
10301 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS
link:presentationLink
link:calculationLink
link:definitionLink
10401 - Disclosure - SHORT-TERM AND LONG-TERM INVESTMENTS
link:presentationLink
link:calculationLink
link:definitionLink
10501 - Disclosure - ACQUISITION OF ZYSTOR THERAPEUTICS, INC.
link:presentationLink
link:calculationLink
link:definitionLink
10601 - Disclosure - ACQUISITION OF LEAD THERAPEUTICS, INC.
link:presentationLink
link:calculationLink
link:definitionLink
10701 - Disclosure - ACQUISITION OF HUXLEY PHARMACEUTICALS, INC.
link:presentationLink
link:calculationLink
link:definitionLink
10801 - Disclosure - INVESTMENT IN SUMMIT CORPORATION PLC
link:presentationLink
link:calculationLink
link:definitionLink
10901 - Disclosure - INVESTMENT IN LA JOLLA PHARMACEUTICAL COMPANY
link:presentationLink
link:calculationLink
link:definitionLink
11001 - Disclosure - GOODWILL
link:presentationLink
link:calculationLink
link:definitionLink
11101 - Disclosure - INTANGIBLE ASSETS
link:presentationLink
link:calculationLink
link:definitionLink
11201 - Disclosure - PROPERTY, PLANT AND EQUIPMENT
link:presentationLink
link:calculationLink
link:definitionLink
11301 - Disclosure - SUPPLEMENTAL BALANCE SHEET INFORMATION
link:presentationLink
link:calculationLink
link:definitionLink
11401 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES
link:presentationLink
link:calculationLink
link:definitionLink
11501 - Disclosure - CONVERTIBLE DEBT
link:presentationLink
link:calculationLink
link:definitionLink
11601 - Disclosure - FAIR VALUE MEASUREMENTS
link:presentationLink
link:calculationLink
link:definitionLink
11701 - Disclosure - STOCKHOLDERS' EQUITY
link:presentationLink
link:calculationLink
link:definitionLink
11801 - Disclosure - STOCK-BASED COMPENSATION
link:presentationLink
link:calculationLink
link:definitionLink
11901 - Disclosure - EARNINGS (LOSS) PER SHARE
link:presentationLink
link:calculationLink
link:definitionLink
12001 - Disclosure - COMPREHENSIVE INCOME (LOSS) AND ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
link:presentationLink
link:calculationLink
link:definitionLink
12101 - Disclosure - REVENUE AND CREDIT CONCENTRATIONS
link:presentationLink
link:calculationLink
link:definitionLink
12201 - Disclosure - INCOME TAXES
link:presentationLink
link:calculationLink
link:definitionLink
12301 - Disclosure - COLLABORATIVE AGREEMENTS
link:presentationLink
link:calculationLink
link:definitionLink
12401 - Disclosure - COMPENSATION AGREEMENTS AND PLANS
link:presentationLink
link:calculationLink
link:definitionLink
12501 - Disclosure - JOINT VENTURE
link:presentationLink
link:calculationLink
link:definitionLink
12601 - Disclosure - COMMITMENTS AND CONTINGENCIES
link:presentationLink
link:calculationLink
link:definitionLink